Jiu-hong Wang

Next-generation sequencing in advanced Chinese melanoma reveals therapeutic targets and prognostic biomarkers for immunotherapy

Bao-yan Zhu, Xiaoshi Zhang, D. Li, 2022, Scientific Reports.

Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanoma

Jing-jing Zhao, Furong Huang, Xiao-shi Zhang, 2021, Journal of Cancer Research and Clinical Oncology.

Adjuvant PD‐1 inhibitor versus high‐dose interferon α‐2b for Chinese patients with cutaneous and acral melanoma: A retrospective cohort analysis

Xiaoshi Zhang, D. Li, Jing-jing Li, 2021, Dermatologic therapy.

HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma

Xiao-Feng Zhu, Xiao-shi Zhang, Qiuxia Ding, 2022, Frontiers in Immunology.